The cost effectiveness of the three kinds of pancreatin inhibitors were evaluated by the pharmacoeconomics method.

• 结果:三组治疗效果差异无显著性,但施他宁组的治疗费用远高于乌司他丁组、善得定组,乌司他丁组最低。